{"product_id":"global-cell-and-gene-therapy-supply-chain-and-logistics-market-growth-status-and-outlook-2023-2029","title":"Global Cell and Gene Therapy Supply Chain and Logistics Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Cell and Gene Therapy Supply Chain and Logistics Market Growth (Status and Outlook) 2023-2029\u003cbr\u003e\nThe global Cell and Gene Therapy Supply Chain and Logistics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eUnited States market for Cell and Gene Therapy Supply Chain and Logistics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eChina market for Cell and Gene Therapy Supply Chain and Logistics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eEurope market for Cell and Gene Therapy Supply Chain and Logistics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eGlobal key Cell and Gene Therapy Supply Chain and Logistics players cover Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Clarkston Consulting and Hypertrust Patient Data Care, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Cell and Gene Therapy Supply Chain and Logistics Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy Supply Chain and Logistics sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy Supply Chain and Logistics sales for 2023 through 2029. With Cell and Gene Therapy Supply Chain and Logistics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy Supply Chain and Logistics industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy Supply Chain and Logistics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Cell and Gene Therapy Supply Chain and Logistics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy Supply Chain and Logistics market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy Supply Chain and Logistics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy Supply Chain and Logistics.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy Supply Chain and Logistics market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nOrdering and Scheduling Services\u003cbr\u003e\nSample Collection Services\u003cbr\u003e\nLogistics Services\u003cbr\u003e\nPost Treatment Follow-Up Services\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nBiobank\u003cbr\u003e\nCell Therapy Lab\u003cbr\u003e\nHospital\u003cbr\u003e\nResearch Institute\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nMexico\u003cbr\u003e\nBrazil\u003cbr\u003e\nAPAC\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nKorea\u003cbr\u003e\nSoutheast Asia\u003cbr\u003e\nIndia\u003cbr\u003e\nAustralia\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUK\u003cbr\u003e\nItaly\u003cbr\u003e\nRussia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\nEgypt\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nIsrael\u003cbr\u003e\nTurkey\u003cbr\u003e\nGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nBe The Match BioTherapies\u003cbr\u003e\nBiocair\u003cbr\u003e\nMarken\u003cbr\u003e\nWorld Courier\u003cbr\u003e\nMAK-SYSTEM\u003cbr\u003e\nCryoport\u003cbr\u003e\nBrooks Life Sciences\u003cbr\u003e\nClarkston Consulting\u003cbr\u003e\nHypertrust Patient Data Care\u003cbr\u003e\nHaemonetics\u003cbr\u003e\nMasterControl\u003cbr\u003e\nTraceLink\u003cbr\u003e\nSAVSU Technologies\u003cbr\u003e\nTrakCel\u003cbr\u003e\nTitle21 Health Solutions\u003cbr\u003e\nsedApta Group\u003cbr\u003e\nVineti\u003cbr\u003e\nStafa Cellular Therapy\u003cbr\u003e\nThermo Fisher Scientific\u003cbr\u003e\nMcKesson\u003cbr\u003e\nBioLife Solutions\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 124 Pages \/ MCW16230230","offer_id":47647058723122,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-cell-and-gene-therapy-supply-chain-and-logistics-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}